Unsere Webseite nutzt Cookies, damit die User-Experience gesteigert wird. Bitte beachten Sie, dass ohne Cookies einige Funktionalitäten nicht mehr ausführbar sind (z.B. Formulare).  Ausführlichere Hinweise zu Cookies
Ok
LMU Munich University Hospital Biomedical Center
  • Our Labs
  • News
  • Publications
  • About us
  • For Patients
  1. Neuroimmunology-Munich
  2. Our Labs
  3. Dornmair Lab

Dornmair Lab – Disease-relevant lymphocytes

  • Research Focus
  • Publications
  • Team
  • PI
  • Funding
Dornmair Lab

We are investigating properties and target antigens of disease-relevant B- and T-cells of patients with multiple sclerosis, encephalitis, narcolepsy, psoriasis, and of other disease conditions. Over the years we have established several techniques that now allow us to distinguish disease-relevant cells from bystander cells and to identify the target antigens of antibodies and CD8+ T cells. To this end, we analyze the lymphocyte repertoire by mRNAseq and isolate disease-relevant cells by flow cytometry and 10X technology from body fluids or by laser microdissection from tissue. From single putatively disease-relevant B- and T-cells we then identify matching chains of antibodies or T cell receptors (TCR), clone their heavy and light or α- and β-chains, and functionally express the antibodies or TCRs in vitro.

We analyze the antigens of antibodies by conventional biochemical methods, and found that “oligoclonal band” antibodies, which are important diagnostic markers in multiple sclerosis and other inflammatory neurological diseases, often recognize debris released from dead cells. By contrast, antibodies from patients with encephalitis may recognize surface proteins on cells in the brain and may thus directly contribute to clinical symptoms.

Due to the very low affinities of TCRs to their target antigens (i.e. MHC/peptide complexes), biochemical methods are not suited for T cell antigen identification. Therefore, we have developed an unbiased technology to identify their as yet unknown antigens. This method is based on plasmid-encoded combinatorial peptide libraries which can be loaded onto class I MHC molecules and an extremely sensitive screening system, which uses fluorescent reporter molecules that are expressed upon T cell activation. This technology may be applied to all conditions where CD8+ T cells are relevant, i.e. to many autoimmune, tumor and infectious diseases.

Dornmair Figure

We bring the bedside to the bench:

The left panel shows T cell infiltrates in the brain of an MS patient. Cells are stained for CD8 molecules and a T cell receptor marker indicating expanded T cell clones. A putatively disease-related clone is indicated by an arrow. The right panel shows "resurrected" T cells that light up green when they recognize their specific antigen.

Contact

PD. Dr. rer. nat. Klaus Dornmair
Klaus.Dornmair@med.uni-muenchen.de 

Key Publications

Beltrán E, Paunovic M, Gebert D, Cesur E, Jeitler M, Höftberger R, Malotka J, Mader S, Kawakami N, Meinl E, Bradl M, Dornmair K, Lassmann H. Archeological neuroimmunology: resurrection of a pathogenic immune response from a historical case sheds light on human autoimmune encephalomyelitis and multiple sclerosis. Acta Neuropathol. 2020 Oct 29. Epub ahead of print.

Beltrán E, Gerdes LA, Hansen J, Flierl-Hecht A, Krebs S, Blum H, Ertl-Wagner B, Barkhof F, Kümpfel T, Hohlfeld R, Dornmair K. Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis. J Clin Invest. 2019 Nov 1;129(11):4758-4768. 

Konjevic Sabolek M, Held K, Beltrán E, Niedl AG, Meinl E, Hohlfeld R, Lassmann H, Dornmair K. Communication of CD8+ T cells with mononuclear phagocytes in multiple sclerosis. Ann Clin Transl Neurol. 2019 Jul;6(7):1151-1164. 

Beltrán E, Nguyen XH, Quériault C, Barateau L, Dauvilliers Y, Dornmair K, Liblau RS. Shared T cell receptor chains in blood memory CD4+ T cells of narcolepsy type 1 patients. J Autoimmun. 2019 Jun;100:1-6. 

Brändle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F, Wekerle H, Hohlfeld R, Dornmair K. Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins. Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7864-9. 

Rühl G, Niedl AG, Patronov A, Siewert K, Pinkert S, Kalemanov M, Friese MA, Attfield KE, Antes I, Hohlfeld R, Dornmair K. Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. Neurol Neuroimmunol Neuroinflamm. 2016 May 17;3(4):e241. 

Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, Nickel J, Vollmer S, Thomas P, Krebs S, Pinkert S, Spannagl M, Held K, Kammerbauer C, Besch R, Dornmair K, Prinz JC. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 2015 Dec 14;212(13):2203-12. 

Beltrán E, Obermeier B, Moser M, Coret F, Simó-Castelló M, Boscá I, Pérez-Miralles F, Villar LM, Senel M, Tumani H, Hohlfeld R, Casanova B, Dornmair K. Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation. Brain. 2014 Oct;137(Pt 10):2703-14. 

Siewert K, Malotka J, Kawakami N, Wekerle H, Hohlfeld R, Dornmair K. Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides. Nat Med. 2012 May;18(5):824-8. 

Krishnamoorthy G, Saxena A, Mars LT, Domingues HS, Mentele R, Ben-Nun A, Lassmann H, Dornmair K, Kurschus FC, Liblau RS, Wekerle H. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med. 2009 Jun;15(6):626-32. 

Obermeier B, Mentele R, Malotka J, Kellermann J, Kümpfel T, Wekerle H, Lottspeich F, Hohlfeld R, Dornmair K. Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med. 2008 Jun;14(6):688-93. 

PD Dr. Klaus Dornmair, 
Principal Investigator

Read more about the PI on the next tab.

Dr. Eduardo Beltrán,
Postdoctoral fellow                            

Dr. Alina Huth,
Postdoctoral fellow                                

Dr. Katharina Deschler,
Postdoctoral fellow                                

Julia Hansen, 
PhD student                                    

David Gebert, 
PhD student                                         

Vladyslav Kavaka, 
MD student                                     

Pauline Graf,
technician                            
                             

Markus Utzt, 
technician                                                                    

PD. Dr. rer. nat. Klaus Dornmair

1984 Diploma in Biochemistry, University of Tübingen.

1987 PhD degree, Max-Planck-Institute of Biology, Tübingen.

1987 – 1988 Postdoctoral Fellow Max-Planck-Institute of Biology, Tübingen.

1988 – 1990 Postdoctoral Fellow, Department of Chemistry, Stanford University, Stanford, CA, USA, sponsored by EMBO.

1990 – 1999 Group Leader, Max-Planck-Institute of Neurobiology, Martinsried.

since 1999 Group Leader, Institute of Clinical Neuroimmunology, LMU Munich

We gratefully acknowledge support for our work by the following agencies:

Germam Research Foundation

More

Munich Cluster for Systems Neurology (SyNergy)

More

LMUexcellent

More

Collaborative Research Center 128 – German Research Foundation (DFG)

More

ERA-Net for Research Programmes on Rare Diseases

More

Bundesministerium für Bildung und Forschung

More

Wilhelm Sander-Stiftung

More

Wilhelm Sander-Stiftung

More

twitter icon

Follow us on Twitter

Contact

Institute of Clinical Neuroimmunology
University Hospital and Biomedical Center
Ludwig-Maximilians University Munich

Director: Prof. Dr. med. Martin Kerschensteiner

Clinical Team:
Marchioninistrasse 15, 81377 Munich
Phone: +49 (0) 89 4400 74781

Research Team:
Grosshaderner Strasse 9, 82152 Martinsried
Phone: : +49 (0) 89 2180 71660

www.neuroimmunology-munich.de

Send a Mail

Partners

BMC – Biomedizinisches Zentrum der LMU München

Neurologische Klinik und Poliklinik der Universität München

SyNergy – Munich Cluster for Systems Neurology

GSN – Graduate School for Systemtic Neurosciences

CRC 128 – Collaborative Research Center 128

CRC 274 – Collaborative Research Center 274

CRC 870 – Collaborative Research Center 870

Verein Therapieforschung für MS-Kranke e.V.

Munich Center for Neurosciences

Redakteurs Log-In
  • Imprint
  • Privacy Policy
  • Contact
© Institute of Clinical Neuroimmunology
  • LMU Munich
  • University Hospital
  • Biomedical Center

    Neuroimmunol...

    • Our Labs
    • News
    • Publications
    • About us
    • For Patients